Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP993172.RAIPxLeVI0Iv1ZMmLw59xIH2ImDEO3lQ9yAznFqbv5_M0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP993172.RAIPxLeVI0Iv1ZMmLw59xIH2ImDEO3lQ9yAznFqbv5_M0130_assertion type Assertion NP993172.RAIPxLeVI0Iv1ZMmLw59xIH2ImDEO3lQ9yAznFqbv5_M0130_head.
- NP993172.RAIPxLeVI0Iv1ZMmLw59xIH2ImDEO3lQ9yAznFqbv5_M0130_assertion description "[mSOD1 microglia isolated from ALS mice at disease onset expressed higher levels of Ym1, CD163 and BDNF (markers of M2) mRNA and lower levels of Nox2 (a marker of M1) mRNA compared with mSOD1 microglia isolated from ALS mice at end-stage disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993172.RAIPxLeVI0Iv1ZMmLw59xIH2ImDEO3lQ9yAznFqbv5_M0130_provenance.
- NP993172.RAIPxLeVI0Iv1ZMmLw59xIH2ImDEO3lQ9yAznFqbv5_M0130_assertion evidence source_evidence_literature NP993172.RAIPxLeVI0Iv1ZMmLw59xIH2ImDEO3lQ9yAznFqbv5_M0130_provenance.
- NP993172.RAIPxLeVI0Iv1ZMmLw59xIH2ImDEO3lQ9yAznFqbv5_M0130_assertion SIO_000772 22735487 NP993172.RAIPxLeVI0Iv1ZMmLw59xIH2ImDEO3lQ9yAznFqbv5_M0130_provenance.
- NP993172.RAIPxLeVI0Iv1ZMmLw59xIH2ImDEO3lQ9yAznFqbv5_M0130_assertion wasDerivedFrom befree-2016 NP993172.RAIPxLeVI0Iv1ZMmLw59xIH2ImDEO3lQ9yAznFqbv5_M0130_provenance.
- NP993172.RAIPxLeVI0Iv1ZMmLw59xIH2ImDEO3lQ9yAznFqbv5_M0130_assertion wasGeneratedBy ECO_0000203 NP993172.RAIPxLeVI0Iv1ZMmLw59xIH2ImDEO3lQ9yAznFqbv5_M0130_provenance.